DeGolyer Donald W — SEC Form 4 filings

SEC reporting owner CIK 1583098. 6 Form 4 filings on record with FilingPulse; latest filed 2026-05-04.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-05-28 to 2026-05-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Emergent BioSolutions Inc. (EBS)Director65 legs · 66,126 sh · $658,1976

Form 4 filings — DeGolyer Donald W

FiledFormIssuerReported transactionsSource
2026-05-044Emergent BioSolutions Inc. (EBS)Grant/award (A): 25,344 @ $0 · Sale (S): 14,527 @ $8.36 · Sale (S): 954 @ $8.96 · Grant/award (A): 11,296 (derivative) @ $0EDGAR
2025-11-124Emergent BioSolutions Inc. (EBS)Sale (S): 17,801 @ $10.54EDGAR
2025-08-134Emergent BioSolutions Inc. (EBS)Sale (S): 7,844 @ $8.65EDGAR
2025-05-024Emergent BioSolutions Inc. (EBS)Grant/award (A): 34,403 @ $0 · Grant/award (A): 15,824 (derivative) @ $0EDGAR
2024-11-144Emergent BioSolutions Inc. (EBS)Sale (S): 25,000 @ $10.91EDGAR
2024-05-284Emergent BioSolutions Inc. (EBS)Grant/award (A): 17,430 @ $0 · Grant/award (A): 25,748 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1583098 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →